BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15025351)

  • 21. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
    Vallbo C; Wang W; Damber JE
    BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum of histological lesions in 185 consecutive prostatic specimens.
    Mittal BV; Amin MB; Kinare SG
    J Postgrad Med; 1989 Jul; 35(3):157-61. PubMed ID: 2483935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Flow cytometric determination of DNA distribution patterns of malignant and benign tumors of the prostate (author's transl)].
    Lämmel A; Roters M; Kastendieck H; Becker H
    Urologe A; 1981 Nov; 20(6):400-4. PubMed ID: 6171922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.
    Singh AP; Chauhan SC; Bafna S; Johansson SL; Smith LM; Moniaux N; Lin MF; Batra SK
    Prostate; 2006 Mar; 66(4):421-9. PubMed ID: 16302265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: cancer association of annexin A3.
    Wozny W; Schroer K; Schwall GP; Poznanović S; Stegmann W; Dietz K; Rogatsch H; Schaefer G; Huebl H; Klocker H; Schrattenholz A; Cahill MA
    Proteomics; 2007 Jan; 7(2):313-22. PubMed ID: 17205602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of fine needle aspiration cytology (FNAC) in the diagnosis of prostatic lesions with histologic correlation.
    Saleh AF; Nahar Rahman AJ; Salam MA; Islam F
    Bangladesh Med Res Counc Bull; 2005 Dec; 31(3):95-103. PubMed ID: 17549870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG; Aiad HA; Sultan SM
    APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of different methods of detecting mucin in adenocarcinomas of the lung.
    Kennedy A; Burgin PD
    Br J Dis Chest; 1975 Apr; 69(2):137-43. PubMed ID: 49191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The distribution of mast cells in benign and malignant prostate lesions and its biologic significance].
    Deng WB; Li P; Li GX; Zhao Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):623-5. PubMed ID: 15460402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argyrophil crystalloids in adenocarcinoma of the prostate.
    Luna-Moré S
    Prostate; 1993; 22(4):309-15. PubMed ID: 7684525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].
    Yu T; Zhu SX; Zheng S; Chen SP
    Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical value of CK34BE12 combining the expression of protein P53 gene and prostate specific antigen for the differential diagnosis of prostate carcinoma].
    Gu XJ; Lu JL; Lai RS; Zhang YD; Zhang P; Lu ZJ; Zhu QY
    Zhonghua Nan Ke Xue; 2006 Apr; 12(4):340-2. PubMed ID: 16683569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucins in prostatic carcinoma.
    Pinder SE; McMahon RF
    Histopathology; 1990 Jan; 16(1):43-6. PubMed ID: 2307414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucin histochemistry--a simple and effective method for diagnosing premalignant and early malignant lesions of lower gastrointestinal tract.
    Gupta SC; Misra V; Singh PA; Misra SP; Srivastava M; Agrawal R
    Indian J Pathol Microbiol; 1997 Jul; 40(3):327-33. PubMed ID: 9354002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between Alcian blue-periodic acid-Schiff stain and immunohistochemical expression of mucin 2 in Barrett's oesophagus.
    Lopes CV; Pereira-Lima JC; Hartmann AA
    Histopathology; 2004 Aug; 45(2):198-9. PubMed ID: 15279642
    [No Abstract]   [Full Text] [Related]  

  • 40. Mammary mucinous carcinoma in the cat.
    Sarli G; Brunetti B; Benazzi C
    Vet Pathol; 2006 Sep; 43(5):667-73. PubMed ID: 16966443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.